Authored by Mikaelle de Oliveira
Scientists are exploring whether a tiny molecule could temporarily stop the production of sperm without permanently affecting fertility. A research team at Cornell University is targeting a specific stage of meiosis, which is the specialised form of cell division involved in producing sperm.
Using a compound called JQ1, the researchers were able to disrupt sperm development in mice and then observe the process returning after the treatment stopped. While JQ1 itself isn’t being developed as a contraceptive for people, the research is being used to test whether targeting this stage of sperm production can lead to a new type of non-hormonal male contraceptive.
It puts a much more precise form of biotechnology at the centre of male contraception, with the research testing whether fertility can be paused without permanently changing the underlying biological process. If that approach can eventually be turned into a safe treatment, it could give men another contraceptive option that is temporary, reversible and doesn’t rely on a permanent procedure.
More from MedTech
Why Does Male Contraception Need A New Approach?
There are still limited options available to men with regard to contraception. Condoms are temporary but require single use, while vasectomies are serious surgical procedures intended to be permanent (even though they can, normally, be reversed). Hormonal approaches have also faced challenges around side effects and the practicalities of taking them consistently.
An approach that could temporarily switch sperm production off and then allow it to return could address some of these limitations. Instead of relying on a barrier during sexual intercourse or making permanent changes to fertility, the idea is to give men more control over when their fertility is active. Something which, in turn, would also have ramifications for women and the way in which they’re expected to use contraception. If there are more high-quality contraceptive options for men, perhaps the onus will no longer be entirely on women.
That’s why the Cornell research goes beyond finding another way to interrupt sperm production. It is testing whether a precise molecular intervention could eventually become a controllable form of contraception that may be used by the general public.
Why Is Male Birth Control So Difficult To Develop?
Sperm production is a continuous process, with cells developing from stem cells in the testes before moving through several stages to become mature sperm. Each stage has to happen properly, leaving the scientists with very little room for error when they are trying to control fertility.
That means researchers need to interrupt sperm production without damaging the cells that are responsible for starting it later again. The Cornell team avoided targeting stem cells that continually produce new sperm because damaging them could cause permanent infertility.
Instead, the researchers looked further along the process, aiming to interrupt sperm development while leaving those stem cells intact. It’s a bit like stopping a production line halfway through rather than switching the whole factory off.
How Does This Technology Work?
The compound used in the Cornell study is the JQ1, a small molecule that interferes with a protein called bromodomain testis-specific protein, or BRDT. Rather than developing JQ1 as a contraceptive itself, the researchers used the compound to test whether BRDT could be used as a target for controlling sperm production.
In this study, the male mice received JQ1 for three weeks, during which the sperm production stopped. Once the treatment ended, sperm production returned within six weeks and the mice were able to reproduce, giving the researchers evidence that targeting this process doesn’t necessarily have to mean permanently affecting fertility.
What Would This Look Like In Practice?
It’s too early to know what a contraceptive based on this approach would actually look like, since the research has only been carried out on mice. The researchers still need to identify targets that can produce the same effect safely, as well as work out how a future treatment could be delivered and how long its effects could last.
If researchers can overcome those challenges, this approach could give men another option beyond condoms, vasectomies and the other hormonal methods that are currently being researched.
There is still a long way to go before any of this could actually become another contraception method. Even so, this research is a good sign for the future of male fertility, and it shows how biotechnology could be used to influence fertility in a temporary and controlled way.
This is just another way in which complex biotechnology and medical technology has the potential to have very real-world ramifications that could improve people’s lives.
